Literature DB >> 33305692

P53 induces senescence in the unstable progeny of aneuploid cells.

Maybelline Giam1, Cheng Kit Wong1, Jun Siong Low1,2, Matteo Sinelli1, Oliver Dreesen3, Giulia Rancati1,3.   

Abstract

Aneuploidy is the condition of having an imbalanced karyotype, which is associated with tumor initiation, evolution, and acquisition of drug-resistant features, possibly by generating heterogeneous populations of cells with distinct genotypes and phenotypes. Multicellular eukaryotes have therefore evolved a range of extrinsic and cell-autonomous mechanisms for restraining proliferation of aneuploid cells, including activation of the tumor suppressor protein p53. However, accumulating evidence indicates that a subset of aneuploid cells can escape p53-mediated growth restriction and continue proliferating in vitro. Here we show that such aneuploid cell lines display a robust modal karyotype and low frequency of chromosomal aberrations despite ongoing chromosome instability. Indeed, while these aneuploid cells are able to survive for extended periods in vitro, their chromosomally unstable progeny remain subject to p53-induced senescence and growth restriction, leading to subsequent elimination from the aneuploid pool. This mechanism helps maintain low levels of heterogeneity in aneuploid populations and may prevent detrimental evolutionary processes such as cancer progression and development of drug resistance.

Entities:  

Keywords:  P53; aneuploidy; genome instability; senescence

Mesh:

Substances:

Year:  2020        PMID: 33305692      PMCID: PMC7781663          DOI: 10.1080/15384101.2020.1850968

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  26 in total

1.  Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy.

Authors:  Teresa Davoli; Hajime Uno; Eric C Wooten; Stephen J Elledge
Journal:  Science       Date:  2017-01-20       Impact factor: 47.728

Review 2.  Short- and long-term effects of chromosome mis-segregation and aneuploidy.

Authors:  Stefano Santaguida; Angelika Amon
Journal:  Nat Rev Mol Cell Biol       Date:  2015-08       Impact factor: 94.444

3.  The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis.

Authors:  Min Li; Xiao Fang; Darren J Baker; Linjie Guo; Xue Gao; Zhubo Wei; Shuhua Han; Jan M van Deursen; Pumin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-27       Impact factor: 11.205

Review 4.  Context is everything: aneuploidy in cancer.

Authors:  Uri Ben-David; Angelika Amon
Journal:  Nat Rev Genet       Date:  2019-09-23       Impact factor: 53.242

5.  Proliferation of aneuploid human cells is limited by a p53-dependent mechanism.

Authors:  Sarah L Thompson; Duane A Compton
Journal:  J Cell Biol       Date:  2010-02-01       Impact factor: 10.539

6.  Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine.

Authors:  Stefano Santaguida; Anthony Tighe; Anna Morena D'Alise; Stephen S Taylor; Andrea Musacchio
Journal:  J Cell Biol       Date:  2010-07-12       Impact factor: 10.539

7.  The Regulation of Multiple p53 Stress Responses is Mediated through MDM2.

Authors:  Wenwei Hu; Zhaohui Feng; Arnold J Levine
Journal:  Genes Cancer       Date:  2012-03

8.  Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3.3 Ser31 phosphorylation.

Authors:  Edward H Hinchcliffe; Charles A Day; Kul B Karanjeet; Sela Fadness; Alyssa Langfald; Kevin T Vaughan; Zigang Dong
Journal:  Nat Cell Biol       Date:  2016-05-02       Impact factor: 28.824

9.  Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations.

Authors:  Aniek Janssen; Marja van der Burg; Karoly Szuhai; Geert J P L Kops; René H Medema
Journal:  Science       Date:  2011-09-30       Impact factor: 47.728

10.  Lamin B1 loss is a senescence-associated biomarker.

Authors:  Adam Freund; Remi-Martin Laberge; Marco Demaria; Judith Campisi
Journal:  Mol Biol Cell       Date:  2012-04-11       Impact factor: 4.138

View more
  3 in total

1.  Extensive protein dosage compensation in aneuploid human cancers.

Authors:  Klaske M Schukken; Jason M Sheltzer
Journal:  Genome Res       Date:  2022-06-14       Impact factor: 9.438

2.  On the role of p53 in the cellular response to aneuploidy.

Authors:  Akshay Narkar; Blake A Johnson; Pandurang Bharne; Jin Zhu; Veena Padmanaban; Debojyoti Biswas; Andrew Fraser; Pablo A Iglesias; Andrew J Ewald; Rong Li
Journal:  Cell Rep       Date:  2021-03-23       Impact factor: 9.423

3.  Non-genetic and genetic rewiring underlie adaptation to hypomorphic alleles of an essential gene.

Authors:  Altea Targa; Katherine E Larrimore; Cheng Kit Wong; Yu Lin Chong; Ronald Fung; Joseph Lee; Hyungwon Choi; Giulia Rancati
Journal:  EMBO J       Date:  2021-09-15       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.